Patents

News Patents

  • Genmab Acquires Antibody Assets from iDD Biotech

    Genmab A/S  announced that its subsidiary Genmab Holding B.V. entered into an agreement to purchase antibodies and related patents and know-how from iDD Biotech SAS.  The pre-clinical stage antibodies are directed to DR5, also known as Trail Receptor 2 (TRAIL-R2), an emerging cancer target.  Under t more

  • Agilent Technologies Secures Patent for CGH Assays

    Agilent Technologies Inc. announced that it was awarded a significant patent for comparative genomic hybridization methods. CGH methods help researchers study genetics and cancer in both basic and clinical research. The U.S. patent (No. 8,232,055) has claims for measuring copy number changes in geno more

  • Carl Zeiss Licences Digital Pathology from Olympus

    Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover meth more

All news on patents

White papers Patents

  • From Sephadex to GE Healthcare

    The success of chromatography as a technique for separating biomolecules is inevitably linked to the introduction of the gel filtration medium Sephadex(TM) by Pharmacia AB in 1959 more

Websites Patents

AKos Consulting & Solutions Deutschland GmbH (AKosGmbH)

AKos Consulting & Solutions GmbH Home Company Info Impressum Contact Email a chemoinformatics company   What is new: Use CWM Global Search Use ACD (Available Chemicals Directory) free of charge Isentris Personal - an extremely powerful and low-cost chemical information system  - get a 30 day free ev more

DermaGen - A valuable contribution to dermatology

Our Company | The Challenge | Technology | Indication | Product Development | Business model | Contacts | News A valuable contribution to dermatology DermaGen develops novel antimicrobial peptides (AMPs) directed against skin microbes, primarily bacteria. These peptide therapeutics kill microbes by more

Home - Pharmaxis

Home About Us Company Overview Innovation and Leadership Products Discovery Company Highlights Company History Our People Senior Management Our Reach Awards and Recognition Australian Industry Participation Purchasing Policy Positions Vacant Legal Disclaimer Our Products Aridol Current clinical tria more

All websites on patents
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE